Perbak Capital Partners LLP Perkinelmer Inc Transaction History
Perbak Capital Partners LLP
- $568 Billion
- Q3 2025
A detailed history of Perbak Capital Partners LLP transactions in Perkinelmer Inc stock. As of the latest transaction made, Perbak Capital Partners LLP holds 16,545 shares of PKI stock, worth $2 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
16,545
Previous 5,668
191.9%
Holding current value
$2 Million
Previous $548 Million
164.53%
% of portfolio
0.26%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding PKI
# of Institutions
594Shares Held
118MCall Options Held
16.8KPut Options Held
71.6K-
T. Rowe Price Investment Management, Inc. Baltimore, MD22.5MShares$2.72 Billion1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$1.64 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY8.78MShares$1.06 Billion0.02% of portfolio
-
Edge Point Investment Group Inc. Toronto, A68.57MShares$1.04 Billion9.32% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.17MShares$989 Million0.08% of portfolio
About PERKINELMER INC
- Ticker PKI
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 126,224,000
- Market Cap $15.3B
- Description
- PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...